Hospitals.clalit.co.il

רדנו הנאיטט ר" –
ד םירקחמו םירמאמ
PUBLICATIONS

1. Valdman S, Vander T, Bersudsky M, Ifergane G, Wirguin I.
The Many Faces of the Guillain-Barre Syndrome.
Neurology 2000;54(Suppl 3):A368. (Presented at the Annual meeting of the
American Academy of Neurology, San Diego, Ca).
2. Vander T, Medvedovsky M, Hallevy H, Gozman G, Herishanu YO. Listeria
monocytogenes
meningitis in a patient with chronic hepatitis C, treated by interferon
alfa and ribavirin. J Infect 2003; 46: 70-71.
3. Vander T, Medvedovsky M, Herishanu YO. Encephalopathy induced by oral
acyclovir in a patient with normal renal function. J Infect 2003; 46: 286.
4. Vander T, Hallevy H, Ifergane G, Herishanu YO. Metformin induced
encephalopathy without lactic acidosis. Diabet Med 2004; 21: 194-195.
5. Vander T, Medvedovsky M, Valdman S, Herishanu YO. Peripheral facial paralysis
and meningitis caused by Rickettsia typhi infection. Scand J Infect Dis 2003; 35: 886-
887.
6. Vander T, Ifergane G. Transient post-ictal urinary retention: Presentation of 3
cases. Eur J Neurol 2004; 11: 207-208.
7. Vander T, Medvedovsky M, Duchanu L, Shelef I, Tomer A, Herishanu YO.
Postmenopausal hormone replacement therapy and dural sinus thrombosis.
Eur J Neurol 2004; 11: 569-71.
8. Vander T, Medvedovsky M, Herishanu YO. Epilepsia partialis continua possibly
caused by cerebellar lesion. Cerebellum 2004; 3: 126-8.
9. Vander T, Hallevy C, Alsaed I, Valdman S, Ifergane G, Wirguin I. Positive 14-3-3
protein in the patient with Hashimoto's encephalopathy. J Neurol 2004;250: 1273-4.
ander T, Odi H, Bluvstein V, Ronen J, Catz A. Carbamazepine toxicity following Oxybutynin and Dantrolene administration – A case report. Spinal cord Rupture of Quadriceps Tendon in a Patient with Postanoxic Choreo-athetosis. Disability and Rehabilitation 2005; 27: 597-599.
irguin I, Vander T, Brenner T, Abramsky O, Steiner I. Improvement of SSPE by intrathecal infusion of alpha-IFN. Neurology 2005; 64: 402.
13. Benmoyal-Segal L, Vander T, Shifman S, Bryk B, Ebstein R, Marcus EL, Stessman J, Darvasi A, Herishanu Y, Friedman A, Soreq H. Acetylcholinesterase/paraoxonase interactions increase the risk of insecticide-induced Parkinson's disease. FASEB J. 2005 Jan 3.
14. Cohen AD, Vander T, Medvendovsky E, Biton A, Naimer S, Shalev R, Vardy DA Neuropathic scrotal pruritus: anogenital pruritus is a symptom of lumbosacral radiculopathy. J Am Acad Dermatol. 2005;52:61-6 15. Hellden, A, Lycke , Vander T, Svensson Jan-Olof , Odar-Cederlof I, Stahle L. The aciclovir metabolite CMMG is detectable in the CSF of subjects with neuropsychiatric symptoms during aciclovir and valaciclovir treatment. Journal of Antimicrobial Chemotherapy. 2006;57(5):945-949 16. Medvedovsky M, Ifergane G, Wirguin I, Vander T, Dori A, Kipervasser S,
Shifrin A, Vakhapova-Danicek V, Neufeld MY.
Epilepsy Behav. 2006;8(2):429-33
17. Oksenberg A, Arons E, Nasser K, Vander T, Radwan H. REM-related obstructive
sleep apnea: the effect of body position. JCSM 2010;6(4):343-348.
RESEARCH

1. Open Label Clinical trial : Topiramate-drug of choice in partial epilepsy treatment.
2. Polymorphism of promoter of gene of AChE in chronically exposed to
organophosphates parkinsonian patients of south Negev ( prof. H. Soreq and dr. A.
Fridman).

Source: http://hospitals.clalit.co.il/hospitals/Loewenstein/he-IL/CustomerInfo/OurDoctors/Documents/%D7%9E%D7%90%D7%9E%D7%A8%D7%99%D7%9D%20%D7%95%D7%9E%D7%97%D7%A7%D7%A8%D7%99%D7%9D%20%E2%80%93%20%D7%93%D7%A8%20%D7%98%D7%98%D7%99%D7%90%D7%A0%D7%94%20%D7%95%D7%A0%D7%93%D7%A8.pdf

Iatrogénèse médicamenteuse

B o n u s a g e M i s e a u p o i n t Prévenir la iatrogénèsemédicamenteuse chez le sujet âgé143/147, bd Anatole France - F-93285 Saint-Denis Cedex tél. +33 (0) 1 55 87 30 00 - fax +33 (0) 1 55 87 30 12 www.afssaps.sante.fr Prévenir la iatrogénèse médicamenteuse chez le sujet âgé La iatrogénèse médicamenteuse constitue un problème de santé publique tout parti

themgo.com

Using Second-Generation Antidepressants to Treat Depressive Disorders: A Clinical Practice Guideline from the American College of Physicians Amir Qaseem, MD, PhD, MHA; Vincenza Snow, MD; Thomas D. Denberg, MD, PhD; Mary Ann Forciea, MD; and Douglas K. Owens, MD, MS, for the Clinical Efficacy Assessment Subcommittee of the American College of Physicians* Description: The American College of Ph

Copyright © 2013-2018 Pharmacy Abstracts